Overview

A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of JNJ-42165279 in Healthy Male Participants

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of repeated administration of 200 mg of itraconazole on the single-dose pharmacokinetics of JNJ-42165279 in healthy male participants.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen Pharmaceutica N.V., Belgium
Treatments:
Hydroxyitraconazole
Itraconazole
JNJ-42165279